India Inc India Inc: Thursday, 07 December 2017 05:22

Clermont Group invests in Indiabulls Pharma

Indiabulls Pharmaceuticals, a recent pharma venture of Indiabulls Group Companies, received Rs 155 crore ($28.85 million) capital from Singapore-based investment firm Clermont Group.

Indiabulls Pharma said this new development will further boost an already rapidly growing business which the company has witnessed since its launch in May 2017.

The investment will bolster the company’s ambition of becoming a leading provider of healthcare products and services in India and be amongst the top 10 players in the coming decade.

Nikhil Chari, CEO, Indiabulls Pharma, said: “At Indiabulls Pharmaceuticals, we want to reshape the Indian pharmaceutical industry landscape by providing next generation therapies to patients at affordable prices. We aspire to be a patient and physician centric, innovative, best-in-class pharmaceutical company.”

The company added that its business aspiration is to be a leading patient and physician centric, best in class, innovative healthcare company.

It operates in both chronic and acute therapies and also across health, wellness and cosmoceutical categories. Currently the company has 300 products under its portfolio many being first time in India formulations and devices. 

India Investment Journal’ has in-depth coverage on related topics.

Login to post comment
Get in Touch
This email address is being protected from spambots. You need JavaScript enabled to view it.

Array ( [format] => html [Itemid] => 148 [option] => com_k2 [view] => item [task] => 6960:clermont-group-invests-in-indiabulls-pharma [id] => 6960:clermont-group-invests-in-indiabulls-pharma )